The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in ...

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

On Thursday, RFK’s Advisory Committee on Immunization Practices (ACIP) voted to recommend clesrovimab, a new RSV antibody shot made by Merck, for infants 8 months and younger who don’t have ...

RSV is the leading cause of hospitalizations among newborns and younger children. Among those under age 5, the CDC reports between 58,000 and 80,000 hospitalizations a year. RFK Jr.'s vaccine ...

The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.

In case you missed: RFK Jr. fires entire CDC vaccine advisory panel The Beyfortus shot was recommended by ACIP in 2023 for babies under 9 months old who are entering their first RSV season.